Biomarkers predicting development of metachronous gastric cancer after endoscopic resection: An analysis of molecular pathology of Helicobacter pylori eradication

International Journal of Cancer

Volumn 130, Issue 10, 2012, Pages 2349-2358

  Watari, Jiro ^a   Moriichi, Kentaro ^b   Tanabe, Hiroki ^b   Kashima, Shin ^b   Nomura, Yoshiki ^b   Fujiya, Mikihiro ^b   Tomita, Toshihiko ^a   Oshima, Tadayuki ^a   Fukui, Hirokazu ^a   Miwa, Hiroto ^a   Das, Kiron M ^c   Kohgo, Yutaka ^b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Das 1; eradication; gastric cancer; Helicobacter pylori; intestinal metaplasia; metachronous; microsatellite instability

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DAS 1; PEROXIDASE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CHRONIC GASTRITIS; CONTROLLED STUDY; EARLY CANCER; ENDOSCOPIC SURGERY; ENZYME ASSAY; ERADICATION THERAPY; FEMALE; GENDER; HELICOBACTER INFECTION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTESTINAL TYPE MUCOSAL GASTRIC CANCER; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; METACHRONOUS GASTRIC CANCER; MICROSATELLITE INSTABILITY; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STOMACH ANTRUM; STOMACH CANCER; SUBMUCOSA;

AGED; ANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; STOMACH NEOPLASMS;

EID: 84859109161     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26275     Document Type: Article

References (44)

1. Lauren P,. The two histological main type of gastric carcinoma: diffuse and so-called intestinal type carcinoma: an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
2. Correa P, Fox J, Fontham E, Ruiz B, Lin Y, Zavala D, Taylor N, Mackinley D, De Lima E, Portilla H, Zarama G,. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66: 2569-74.
3. Sipponen P, Hyvärinen H,. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 1993; 196 (Suppl): 3-6. (Pubitemid 23175425)
4. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori, vol. 61. Lyon: IARC, 1994. 177-240.
5. Graham DY,. Helicobacter pylori infection is the primary cause of gastric cancer. J Gastroenterol 2000; 35 (Suppl 12): 90-97. (Pubitemid 30229727)
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ,. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
7. Correa P,. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19: S37-S43.
8. Correa P,. A human model of gastric carcinogenesis. Cancer Res 1988; 48: 3554-60.
9. Filipe MI, Muñoz N, Matko I, Kato I, Pompe-Kirn V, Jutersek A, Teuchmann S, Benz M, Prijon T,. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994; 57: 324-9. (Pubitemid 24168604)
10. You WC, Zhang L, Gail MH, You WC, Zhang L, Gail MH, Chang YS, Liu WD, Ma JL, Li JY, Jin ML, Hu YR, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000; 92: 1607-12.
11. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K, Okada H, Shiratori Y,. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005; 100: 1037-42. (Pubitemid 40769039)
12. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94. (Pubitemid 38082812)
13. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M,; Japan Gast Study Group. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randamised controlled trial. Lancet 2008; 372: 392-7.
14. Correa P,. Human gastric carcinogenesis: a multistep and multifactorial process, First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-40. (Pubitemid 23006271)
15. Hiyama T, Yokozaki H, Kitadai Y, Tahara E, Tahara H, Ide T, Haruma K, Yasui W, Kajiyama G, Tahara E,. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesion lesions. Jpn J Cancer Res 1998; 89: 1187-94. (Pubitemid 29008000)
16. Lengauer C, Kinzler KW, Vogelstein B,. Genetic instabilities in human cancers. Nature 1998; 396: 643-649. (Pubitemid 29003936)
17. Tanaka A, Watari J, Tanabe H, Maemoto A, Fujiya M, Ashida T, Das KM, Kohgo Y,. Effect of eradication of Helicobacter pylori on genetic instabilities in gastric intestinal metaplasia. Aliment Pharmacol Ther 2006; 24 (Suppl 4): 194-202.
18. Zaky A, Watari J, Tanabe H, Sato R, Moriichi K, Tanaka A, Maemoto A, Fujiya M, Ashida T, Kohgo Y,. Clinicopathological implications of genetic instability in intestinal type gastric cancer and intestinal metaplasia as a precancerous lesion: proof of field cancerization in the stomach. Am J Clin Pathol 2008; 129: 613-21. (Pubitemid 352029281)
19. Miyoshi E, Haruma K, Hiyama T, Tanaka S, Yoshihara M, Shimamoto F, Chayama K,. Microsatellite instability is a genetic marker for the development of multiple gastric cancers. Int J Cancer 2001; 95: 350-3. (Pubitemid 33015103)
20. Hasuo T, Semba S, Li D, Omori Y, Shirasaka D, Aoyama N, Yokozaki H,. Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer. Br J Cancer 2007; 96: 89-94. (Pubitemid 46094644)
21. Das KM, Sakamaki S, Vecchi M, Diamond B,. The production and characterization of monoclonal antibodies to a human colonic antigen associated with ulcerative colitis: cellular localization of the antigen by using the monoclonal antibody. J Immunol 1987; 139: 77-84. (Pubitemid 17091764)
22. Filipe MI, Jass JR,. Intestinal metaplasia subtypes and cancer risk. In:, Filipe MI, Jass JR, eds. Gastric carcinoma. Edinburgh: Churchill Livingstone, 1986. 212-36.
23. Mirza ZK, Das KK, Slate J, Mapitigama RN, Amenta PS, Griffel LH, Ramsundar L, Watari J, Yokota K, Tanabe H, Sato T, Kohgo Y, et al. Gastric intestinal metaplasia as detected by a novel biomarker is highly associated with gastric adenocarcinoma. Gut 2003; 52: 807-12. (Pubitemid 36613486)
24. Watari J, Das KK, Amenta PS, Tanabe H, Tanaka A, Geng X, Lin JJ, Kohgo Y, Das KM,. Effect of eradication of Helicobacter pylori on the histology and cellular phenotype of gastric intestinal metaplasia. Clin Gastroenterol Hepatol 2008; 6: 409-17.
25. de Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, van Grieken NC, Kuipers EJ,. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007; 56: 1665-70. (Pubitemid 350206290)
26. Japanese Research Society for Gastric Cancer. The general rules for gastric cancer study, 12th edn. Tokyo: Kinbara Publication, 1993.
27. Moriichi K, Watari J, Das KM, Tanabe H, Fujiya M, Ashida T, Kohgo Y,. Effects of Helicobacter pylori infection on genetic instability, the aberrant CpG island methylation status and the cellular phenotype in Barrett's esophagus in a Japanese population. Int J Cancer 2009; 124: 1263-9.
28. Oda S, Oki E, Maehara Y, Sugimachi K,. Precise assessment of microsatellite instability using high resolution fluorescent microsatellite analysis. Nucleic Acids Res 1997; 25: 3415-20. (Pubitemid 27359214)
29. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S,. National Cancer Institute on Workshop on Microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248-57. (Pubitemid 28521189)
30. Ward R, Meagher A, Tomlinson I, O'Connor T, Norrie M, Wu R, Hawkins N,. Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Gut 2001; 48: 821-9. (Pubitemid 32476985)
31. Kim H, Jen J, Vogelstein B, Hamilton SR,. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994; 145: 148-56. (Pubitemid 24217493)
32. Laiho P, Launonen V, Lahermo P, Esteller M, Guo M, Herman JG, Mecklin JP, Järvinen H, Sistonen P, Kim KM, Shibata D, Houlston RS, et al. Low-level microsatellite instability in most colorectal carcinomas. Cancer Res 2002; 62: 1166-70. (Pubitemid 34160304)
33. Das KM, Prasad I, Garla S, Amenta PS,. Detection of a shared colon epithelial epitope on Barrett epithelium by a novel monoclonal antibody. Ann Intern Med 1994; 120: 753-6. (Pubitemid 24125296)
34. Chung YJ, Song JM, Lee JY, Jung YT, Seo EJ, Choi SW, Rhyu MG,. Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population. Cancer Res 1996; 56: 4662-5.
35. Buonsanti G, Calistri D, Padovan L, Luinetti O, Fiocca R, Solcia E, Ranzani GN,. Microsatellite instability in intestinal- and diffuse-type gastric carcinoma. J Pathol 1997; 182: 167-73. (Pubitemid 27287837)
36. Brentnall TA, Crispin DA, Bronner MP, Cherian SP, Hueffed M, Rabinovitch PS, Rubin CE, Haggitt RC, Boland CR,. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996; 56: 1237-40. (Pubitemid 26080961)
37. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S,. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis-a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology 2000; 32: 970-9.
38. Kashiwagi K, Watanabe M, Ezaki T, Kanai T, Ishii H, Mukai M, Hibi T,. Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis. Br J Cancer 2000; 82: 1814-18. (Pubitemid 30307394)
39. Forné M, Fernández-Bañares F, González- Mínguez C, Casalots J, Poblet-Mas N, Garcia-Gil LJ, Esteve M, Rosinach M, Espinõs J, Loras C, Salas A, Viver JM,. Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia. Am J Clin Pathol 2009; 131: 99-105.
40. Das KM,. Lack of clinical usefulness of Das-1 monoclonal antibody and mucin expression as risk markers of gastric carcinoma in patients with gastric intestinal metaplasia-to the editor. Am J Clin Pathol 2010; 133: 980.
41. Ohmura K, Tamura G, Endoh Y, Sakata K, Takahashi T, Motoyama T,. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype. Hum Pathol 2000; 31: 1031-5.
42. Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, Motoyama T,. Celular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000; 191: 257-63. (Pubitemid 30441248)
43. Watari J, Saitoh Y, Fujiya M, Shibata N, Tanabe H, Inaba Y, Okamoto K, Maemoto A, Ohta T, Yasuda A, Ayabe T, Ashida T, et al. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype. J Gastroenterol 2004; 39: 104-12. (Pubitemid 38325185)
44. Wright NA,. Gastric carcinogenesis: when is the point of no return? In:, Hunt RH, Tytgat GNJ, eds. Helicobacter pylori: basic mechanisms to clinical cure. Boston, Mass: Kluwer Academic Publishers, 1998. 325-35.